Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Schizophrenia research and treatment, Treatment of Major Depression, Tryptophan and brain disorders, and Cardiac Health and Mental Health.
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity
Efficacy of deep brain stimulation for obsessive-compulsive disorder: umbrella review and updated meta-analysis
Psychological and Psychopharmacological Interventions in Psychocardiology
Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension
Heart and brain interactions
Novel aspects of age-protection by spermidine supplementation are associated with preserved telomere length
Oscillatory activity in the BNST/ALIC and the frontal cortex in OCD: acute effects of DBS
Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?
Secondary Traumatic Stress, Mental State, and Work Ability in Nurses—Results of a Psychological Risk Assessment at a University Hospital
Assessment of Major Mental Disorders in a German Peripartum Cardiomyopathy Cohort
Altered neurometabolism in major depressive disorder: A whole brain 1H-magnetic resonance spectroscopic imaging study at 3T
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial
Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)
Relationship between sedentary behavior and depression: A mediation analysis of influential factors across the lifespan among 42,469 people in low- and middle-income countries
Epigenetics in Personality Disorders: Today's Insights
Alcohol, microbiome, and their effect on psychiatric disorders
Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells
Effects of Aging on the Human Brain: A Proton and Phosphorus MR Spectroscopy Study at 3T
Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism
The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis
Relationship between depression and frailty in older adults: A systematic review and meta-analysis
Depression and physical health multimorbidity: primary data and country-wide meta-analysis of population data from 190 593 people across 43 low- and middle-income countries
Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system
Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries
Effects of a 72 hours fasting on brain metabolism in healthy women studied in vivo with magnetic resonance spectroscopic imaging
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics
Mental disorders in adults with congenital heart disease: Unmet needs and impact on quality of life
The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta‐analysis of randomized‐controlled clinical trials
Physiological neuronal decline in healthy aging human brain — An in vivo study with MRI and short echo-time whole-brain 1H MR spectroscopic imaging